Market
First organization to change trimetazidine policy in 2025?
2
Resolution / Starting Odds
WADA • 25%
ITIA • 25%
IOC • 25%
None • 25%
Official announcements from relevant organizations
Story
WADA Will Not Appeal Iga Swiatek's One-Month Suspension for Trimethazidine from August 2024
Jan 20, 2025, 10:58 AM
The World Anti-Doping Agency (WADA) has decided not to appeal the one-month suspension of Polish tennis player Iga Swiatek. This decision follows a comprehensive review of the case file related to the International Tennis Integrity Agency's (ITIA) ruling, which WADA received on November 29, 2024. WADA's scientific experts confirmed that Swiatek's positive test for trimetazidine, a banned substance, was due to a specific contaminated melatonin scenario. The suspension, which was imposed after a positive test during an out-of-competition check in August 2024, will remain in effect without further legal challenge from WADA.
View original story
Similar markets
Other • 25%
World Health Organization (WHO) • 25%
National Institutes of Health (NIH) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
No • 50%
Yes • 50%
European Medicines Agency (EMA) • 25%
Health Canada • 25%
Medicines and Healthcare products Regulatory Agency (MHRA) • 25%
Other • 25%
Other • 25%
American Lung Association • 25%
American Heart Association • 25%
American Cancer Society • 25%
Imperial Brands • 25%
British American Tobacco • 25%
Other • 25%
Altria • 25%
United States • 25%
Other • 25%
France • 25%
India • 25%
WHO • 25%
CDC • 25%
European Medicines Agency • 25%
Other • 25%
No major impact on any organization • 25%
Pfizer • 25%
Public Health Organizations • 25%
FDA • 25%
BLA submission • 25%
No progress • 25%
Conditional approval • 25%
Phase III trial initiation • 25%
Conduct further studies • 25%
Dismiss the findings • 25%
No official response • 25%
Issue new warnings • 25%
Other • 25%
British Medical Association • 25%
American Medical Association • 25%
European Association for the Study of Obesity • 25%